Quote | Foghorn Therapeutics Inc. (NASDAQ:FHTX)
Last: | $5.51 |
---|---|
Change Percent: | -0.86% |
Open: | $5.86 |
Close: | $5.51 |
High: | $6.02 |
Low: | $5.47 |
Volume: | 60,661 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | Foghorn Therapeutics Inc. (NASDAQ:FHTX)
2024-05-06 12:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-06 07:58:09 ET More on Foghorn Therapeutics Foghorn Therapeutics appoints Kristian Humer as chief financial officer Foghorn says Eli Lilly picked lung cancer candidate for further studies Seeking Alpha’s Quant Rating on Foghorn Therapeutics His...
Message Board Posts | Foghorn Therapeutics Inc. (NASDAQ:FHTX)
Subject | By | Source | When |
---|---|---|---|
Long and strong lets hope im right | crudeoil24 | investorshub | 06/27/2023 4:16:58 AM |
$FHTX news all the way baby | crudeoil24 | investorshub | 06/25/2023 10:25:45 PM |
$FHTX is it bear time? Or do we go bull? | crudeoil24 | investorshub | 06/20/2023 6:01:01 AM |
$FHTX Long and strong lets hope im right | Surfacetite | investorshub | 06/14/2023 6:34:57 AM |
great news | crudeoil24 | investorshub | 06/13/2023 3:47:02 AM |
News, Short Squeeze, Breakout and More Instantly...
Foghorn Therapeutics Inc. Company Name:
FHTX Stock Symbol:
NASDAQ Market:
2024-05-06 12:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Dose escalation in FHD-286 combination trial in AML continues to progress with clinical data expected in the second half of 2024; potential to be a first-in-class oral broad-based differentiation therapeutic in AML IND filing submitted for FHD-909, a first-in-class oral BRM (SMARCA2) sele...
2024-04-26 18:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...